Phase 1 Locally Advanced/Metastatic Solid Tumors Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Locally Advanced/Metastatic Solid Tumors
Crescent Biopharma, Inc.290 enrolled17 locationsNCT07335497
Recruiting
Phase 1
Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
Locally Advanced/Metastatic Solid Tumors
InSilico Medicine Hong Kong Limited80 enrolled9 locationsNCT06414460
Recruiting
Phase 1
Study of ESG406 in Adults With Solid Tumors
Locally Advanced/Metastatic Solid Tumors
Shanghai Escugen Biotechnology Co., Ltd556 enrolled3 locationsNCT06979674
Recruiting
Phase 1Phase 2
PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor
Locally Advanced/Metastatic Solid Tumors
Shanghai HyaMab Biotech Co.,Ltd.120 enrolled1 locationNCT05801237